Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) Receives $37.20 Average Price Target from Analysts
Shares of Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX – Get Free Report) have received a consensus recommendation of “Moderate Buy” from the twelve research firms that are currently covering the stock, MarketBeat.com reports. One investment analyst has rated the stock with a sell recommendation, one has issued a hold recommendation, nine have assigned a buy recommendation and […]
1 Mar 07:32 · The Markets Daily